Manufacturing news briefs – stories you might have missed

LBT Innovations receives APAS instrument orders Laboratory device manufacturer LBT Innovations has received an order for multiple APAS instruments from its US distributor Remel Inc, a division of Thermo Fisher Scientific. The company has been commercialising its APAS Independence laboratory instrument, an imaging, interpretation, sorting and reporting machine that automatically examines culture plates for the…

Australian Vanadium backed to produce critical battery materials

Resources and chemicals group Australian Vanadium Limited (AVL) will receive a $49 million grant from the federal government to support a major project in Western Australia to produce critical battery metals and electrolyte for vanadium redox storage batteries. The grant, under the federal government’s Modern Manufacturing Initiative Collaboration Stream, will fund development of the company’s…

Help Australian manufacturers fightback from floods

The Australian Made Campaign is encouraging consumers to help local businesses fight back across flood devastated Queensland and New South Wales through its new ‘Flood Fightback‘ product page. While rain is finally easing Australian Made is featuring almost 900 businesses across flood-affected communities, providing consumers with a way to discover new and exciting Australian Made…

ANSTO to manufacture skin cancer treatment

Nuclear science and technology organisation ANSTO has been licensed as the Australian manufacturing partner of a new non-invasive treatment for non-melanoma skin cancer (NMSC). Radioisotope developer OncoBeta and ANSTO will establish local manufacturing of the company’s epidermal radioisotope therapy, Rhenium-SCT (Skin Cancer Therapy) for the treatment of non-melanoma skin cancer. ANSTO operates the OPAL nuclear…

Manufacturing news briefs – stories you might have missed

Amaero International to review strategic alternatives Additive manufacturing technology company Amaero International has commissioned investment and advisory firm Guggenheim Securities to evaluate strategic alternatives for the company. The study was aimed at ensuring it was ‘taking every step possible to maximise value for shareholders’, according to an announcement. Amaero said no decisions had been made…